Kissei Pharmaceutical Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Kissei Pharmaceutical has a total shareholder equity of ¥220.9B and total debt of ¥1.3B, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are ¥257.9B and ¥37.0B respectively. Kissei Pharmaceutical's EBIT is ¥4.5B making its interest coverage ratio -3.5. It has cash and short-term investments of ¥45.9B.
Wichtige Informationen
0.6%
Verhältnis von Schulden zu Eigenkapital
JP¥1.34b
Verschuldung
| Zinsdeckungsgrad | -3.5x |
| Bargeld | JP¥45.89b |
| Eigenkapital | JP¥220.92b |
| Gesamtverbindlichkeiten | JP¥37.00b |
| Gesamtvermögen | JP¥257.91b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: KSPH.F's short term assets (¥104.8B) exceed its short term liabilities (¥16.0B).
Langfristige Verbindlichkeiten: KSPH.F's short term assets (¥104.8B) exceed its long term liabilities (¥21.0B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: KSPH.F has more cash than its total debt.
Schulden abbauen: KSPH.F's debt to equity ratio has reduced from 2% to 0.6% over the past 5 years.
Schuldendeckung: KSPH.F's operating cash flow is negative, therefore debt is not well covered.
Zinsdeckung: KSPH.F earns more interest than it pays, so coverage of interest payments is not a concern.